Decision Diagnostics Corp. (DECN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -29.66 Million USD | -847.18% |
| 2019 | -3.13 Million USD | -39.82% |
| 2018 | -2.24 Million USD | 25.11% |
| 2017 | -2.99 Million USD | -0.81% |
| 2016 | -2.96 Million USD | -34.5% |
| 2015 | -2.2 Million USD | 0.0% |
| 2012 | -3.08 Million USD | -45.56% |
| 2011 | -2.11 Million USD | -348.67% |
| 2010 | -471.83 Thousand USD | -128.01% |
| 2009 | 1.68 Million USD | 797.02% |
| 2008 | 187.77 Thousand USD | 113.32% |
| 2007 | -1.4 Million USD | 48.82% |
| 2006 | -2.75 Million USD | 42.89% |
| 2005 | -4.82 Million USD | -5.98% |
| 2004 | -4.55 Million USD | -109.84% |
| 2003 | -2.16 Million USD | -10.08% |
| 2002 | -1.97 Million USD | -303.1% |
| 2001 | -488.75 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q2 | -301.56 Thousand USD | 68.98% |
| 2021 Q3 | -554.92 Thousand USD | -84.01% |
| 2021 Q1 | -972.23 Thousand USD | 86.01% |
| 2020 FY | -29.66 Million USD | -847.18% |
| 2020 Q1 | -768.46 Thousand USD | 64.06% |
| 2020 Q2 | -17.21 Million USD | -2140.19% |
| 2020 Q3 | -4.73 Million USD | 72.49% |
| 2020 Q4 | -6.94 Million USD | -46.77% |
| 2019 Q4 | -2.13 Million USD | -577.16% |
| 2019 Q3 | -315.79 Thousand USD | -154.96% |
| 2019 FY | -3.13 Million USD | -39.82% |
| 2019 Q2 | 574.53 Thousand USD | 145.66% |
| 2019 Q1 | -1.25 Million USD | -236.76% |
| 2018 Q1 | -573.15 Thousand USD | 51.87% |
| 2018 Q4 | -373.66 Thousand USD | 49.19% |
| 2018 FY | -2.24 Million USD | 25.11% |
| 2018 Q2 | -558.03 Thousand USD | 2.64% |
| 2018 Q3 | -735.36 Thousand USD | -31.78% |
| 2017 Q2 | -606.42 Thousand USD | -39.14% |
| 2017 Q1 | -435.82 Thousand USD | -104.89% |
| 2017 FY | -2.99 Million USD | -0.81% |
| 2017 Q4 | -1.19 Million USD | -57.07% |
| 2017 Q3 | -758.21 Thousand USD | -25.03% |
| 2016 Q3 | -1.29 Million USD | -503.94% |
| 2016 FY | -2.96 Million USD | -34.5% |
| 2016 Q4 | -212.71 Thousand USD | 83.54% |
| 2016 Q2 | -214.03 Thousand USD | 85.35% |
| 2016 Q1 | -1.46 Million USD | -158.57% |
| 2015 Q2 | -471.95 Thousand USD | 72.06% |
| 2015 Q4 | -565.17 Thousand USD | -133.85% |
| 2015 Q3 | -241.68 Thousand USD | 48.79% |
| 2015 Q1 | -1.68 Million USD | 0.0% |
| 2015 FY | -2.2 Million USD | 0.0% |
| 2014 Q2 | -513.03 Thousand USD | -3.1% |
| 2014 Q1 | -497.62 Thousand USD | 0.0% |
| 2013 Q3 | -771.96 Thousand USD | 56.65% |
| 2013 Q2 | -1.78 Million USD | -91.11% |
| 2013 Q1 | -931.85 Thousand USD | 48.03% |
| 2012 Q4 | -1.79 Million USD | -302.83% |
| 2012 Q2 | -755.88 Thousand USD | -617.54% |
| 2012 Q3 | -445.13 Thousand USD | 41.11% |
| 2012 Q1 | -105.34 Thousand USD | 92.45% |
| 2012 FY | -3.08 Million USD | -45.56% |
| 2011 Q4 | -1.39 Million USD | -215.91% |
| 2011 Q2 | 87.32 Thousand USD | 125.62% |
| 2011 Q1 | -340.78 Thousand USD | 67.71% |
| 2011 FY | -2.11 Million USD | -348.67% |
| 2011 Q3 | -441.85 Thousand USD | -606.01% |
| 2010 Q2 | 276.74 Thousand USD | 62.54% |
| 2010 Q3 | 138.28 Thousand USD | -50.03% |
| 2010 FY | -471.83 Thousand USD | -128.01% |
| 2010 Q4 | -1.05 Million USD | -863.15% |
| 2010 Q1 | 170.26 Thousand USD | 256.6% |
| 2009 Q2 | 1.31 Million USD | 1260.53% |
| 2009 Q3 | 229.27 Thousand USD | -82.51% |
| 2009 Q4 | 47.74 Thousand USD | -79.17% |
| 2009 FY | 1.68 Million USD | 797.02% |
| 2009 Q1 | 96.35 Thousand USD | -52.89% |
| 2008 Q2 | 17.65 Thousand USD | -57.7% |
| 2008 Q4 | 204.54 Thousand USD | 368.6% |
| 2008 Q3 | -76.15 Thousand USD | -531.42% |
| 2008 Q1 | 41.73 Thousand USD | 106.03% |
| 2008 FY | 187.77 Thousand USD | 113.32% |
| 2007 Q4 | -692.47 Thousand USD | -323.4% |
| 2007 Q3 | -163.55 Thousand USD | -8.62% |
| 2007 Q2 | -150.57 Thousand USD | 62.65% |
| 2007 Q1 | -403.18 Thousand USD | 73.85% |
| 2007 FY | -1.4 Million USD | 48.82% |
| 2006 Q2 | -583.93 Thousand USD | -1568.51% |
| 2006 Q3 | -669.1 Thousand USD | -14.59% |
| 2006 Q4 | -1.54 Million USD | -130.39% |
| 2006 FY | -2.75 Million USD | 42.89% |
| 2006 Q1 | 39.76 Thousand USD | 102.41% |
| 2005 Q1 | -1.48 Million USD | -51.81% |
| 2005 Q2 | -818.02 Thousand USD | 44.91% |
| 2005 Q4 | -1.64 Million USD | -88.65% |
| 2005 Q3 | -873.16 Thousand USD | -6.74% |
| 2005 FY | -4.82 Million USD | -5.98% |
| 2004 FY | -4.55 Million USD | -109.84% |
| 2004 Q3 | -763.53 Thousand USD | 26.31% |
| 2004 Q2 | -1.03 Million USD | 41.02% |
| 2004 Q1 | -1.75 Million USD | -77.09% |
| 2004 Q4 | -978.12 Thousand USD | -28.1% |
| 2003 Q3 | -343.71 Thousand USD | 9.07% |
| 2003 Q1 | -406.46 Thousand USD | 52.37% |
| 2003 Q2 | -377.97 Thousand USD | 7.01% |
| 2003 FY | -2.16 Million USD | -10.08% |
| 2003 Q4 | -991.99 Thousand USD | -188.61% |
| 2002 Q2 | -293.04 Thousand USD | -16.4% |
| 2002 Q4 | -853.41 Thousand USD | -65.13% |
| 2002 Q3 | -516.82 Thousand USD | -76.36% |
| 2002 FY | -1.97 Million USD | -303.1% |
| 2002 Q1 | -251.75 Thousand USD | 0.0% |
| 2001 FY | -488.75 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -3703.18 USD | 100.0% |
| Allstar Health Brands, Inc. | -499.34 Thousand USD | 100.0% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 69.18 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | -750.15 Thousand USD | 100.0% |
| Health Advance Inc. | -49.02 Thousand USD | 100.0% |
| HealthWarehouse.com, Inc. | -1.77 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | 52.15 Million USD | 100.0% |
| MedGen, Inc. | -15.54 USD | 100.0% |
| Omni Health, Inc. | 1.26 Million USD | 100.0% |
| Oxford Investments Holdings Inc. | -299.1 Thousand USD | 100.0% |
| Pineapple, Inc. | -1.47 Million USD | 100.0% |
| ScripsAmerica, Inc. | -4.73 Million USD | 100.0% |